Skip to main content
Year archive

Immuron Ltd — 2023 filings

All 79 regulatory filings released by Immuron Ltd (IMRN) in 2023, sourced directly from the official regulator.

79 Filings
2023 Period
2023 filings (79)
Filing Released Lang
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-12-22 English
Immuron Clinical Trials Update 3 pages 311.8KB
Regulatory Filings
2023-12-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-12-04 English
First Patients Enrolled in Campylobacter Clinical Study 2 pages 322.9KB
Regulatory Filings
2023-12-03 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-11-28 English
Investor Webinar Presentation 14 pages 1.8MB
Regulatory Filings
2023-11-27 English
Notification regarding unquoted securities - IMC 6 pages 28.5KB
Regulatory Filings
2023-11-23 English
Change of Director's Interest Notice (PB) 2 pages 204.1KB
Regulatory Filings
2023-11-23 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-11-22 English
Amended Constitution 53 pages 805.3KB
Regulatory Filings
2023-11-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-11-21 English
Presentation to Annual General Meeting 10 pages 881.1KB
Regulatory Filings
2023-11-20 English
Results of Annual General Meeting 2 pages 139.1KB
Regulatory Filings
2023-11-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-11-13 English
Investor Webinar Presentation 13 pages 1.7MB
Regulatory Filings
2023-11-12 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-10-30 English
Immuron CEO, Steven Lydeamore to present at AusBioInvest 12 pages 1.6MB
Regulatory Filings
2023-10-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-10-23 English
Notice of Annual General Meeting/Proxy Form 39 pages 572.7KB
Regulatory Filings
2023-10-22 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-10-18 English
Travelan Clinical Study Cohort 2 commences 2 pages 321.9KB
Regulatory Filings
2023-10-17 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-10-11 English
Immuron achieves record quarterly Travelan sales 3 pages 299.4KB
Regulatory Filings
2023-10-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-10-04 English
Immuron CEO, Steven Lydeamore to present at LD Micro 14 pages 1.8MB
Regulatory Filings
2023-10-03 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-09-28 English
ANNUAL REPORT
Annual Report FY 2023
2023-09-28 English
Annual Report to shareholders 185 pages 4.5MB
Regulatory Filings
2023-09-27 English
Corporate Governance Statement 7 pages 253.7KB
Regulatory Filings
2023-09-27 English
Appendix 4G 12 pages 355.5KB
Regulatory Filings
2023-09-27 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-09-13 English
Immuron achieves record monthly Travelan sales 3 pages 280.2KB
Regulatory Filings
2023-09-12 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-09-11 English
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright 15 pages 2.0MB
Regulatory Filings
2023-09-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-08-30 English
Appendix 4E Preliminary Final Report 14 pages 2.2MB
Regulatory Filings
2023-08-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-08-14 English
Immuron present to Military Health System Research Symposium 5 pages 481.9KB
Regulatory Filings
2023-08-13 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-08-09 English
Immuron Receives TGA GMP Clearance 2 pages 295.0KB
Regulatory Filings
2023-08-08 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-07-25 English
Immuron enrols patients in Travelan clinical study 2 pages 322.9KB
Regulatory Filings
2023-07-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-07-24 English
Immuron CEO, Steven Lydeamore to present at Bioshares 17 pages 1.9MB
Regulatory Filings
2023-07-23 English
Notification regarding unquoted securities - IMC 7 pages 30.7KB
Regulatory Filings
2023-07-11 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-07-11 English
Letter to Shareholders 3 pages 305.9KB
Regulatory Filings
2023-07-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-07-06 English
Immuron FY23 Sales increase 136% on FY22 Sales 2 pages 298.4KB
Regulatory Filings
2023-07-04 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-06-30 English
Immuron Chairman Transition 2 pages 270.8KB
Regulatory Filings
2023-06-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-06-22 English
Letter to Shareholders 2 pages 328.7KB
Regulatory Filings
2023-06-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-06-07 English
Immuron CEO, Steven Lydeamore presents at LD Micro 16 pages 2.1MB
Regulatory Filings
2023-06-06 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-05-30 English
Immuron Initiates Recruitment of Travelan Clinical Study 3 pages 317.8KB
Regulatory Filings
2023-05-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-05-08 English
FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic 3 pages 316.2KB
Regulatory Filings
2023-05-07 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-05-02 English
IMC CEO Steven Lydeamore to present at Coffee Microcaps 17 pages 1.2MB
Regulatory Filings
2023-05-01 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-04-19 English
Q3 FY23 Business Update Presentation 13 pages 697.9KB
Regulatory Filings
2023-04-18 English
Q3 FY23 Business Update Webinar 2 pages 295.2KB
Regulatory Filings
2023-04-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-04-06 English
Immuron Q3 Sales reach 150% of 1H Sales 2 pages 269.9KB
Regulatory Filings
2023-04-05 English
Notification of cessation of securities - IMC 4 pages 24.2KB
Regulatory Filings
2023-03-15 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-02-28 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-02-28 English
Business Update Presentation 14 pages 765.9KB
Regulatory Filings
2023-02-27 English
Appendix 4D and Half Year Report 35 pages 2.9MB
Regulatory Filings
2023-02-27 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-02-15 English
Immuron CEO Steven Lydeamore to host investor webinar 2 pages 218.1KB
Regulatory Filings
2023-02-14 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-01-25 English
Immuron and US NMRC respond to CampETEC FDA Clinical Hold 2 pages 263.1KB
Regulatory Filings
2023-01-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-01-18 English
US DOD Travelan Clinical Recruitment Milestone 2 pages 295.7KB
Regulatory Filings
2023-01-17 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2023-01-17 English
Immuron Receives European Patent on Drug Composition 2 pages 363.8KB
Regulatory Filings
2023-01-16 English